BSC® Knowledge Base
In-Depth Insights Gathered Over Four Decades.
September 18, 2026
Clinical Data Presentations for Orthopedic Device Applications
FDA Regulatory Strategy
September 18, 2026
The Endpoint Hierarchy: Primary vs Secondary vs Exploratory
Trial Design & Methodology
September 24, 2026
Multiple Endpoints: Why Manufacturers Can't Ignore Multiplicity
Trial Design & Methodology
September 24, 2026
The Critical Role of Radiographic Data in Device Clinical Trials
Trial Design & Methodology
WHAT CLIENTS SAY
“They listen the first time. I’ve never had to go back and respell out what I needed."
”They work to understand the problem and leverage the information that is already there.”
Former FDA Regulator
WHAT CLIENTS SAY
"Battle ground tested."
"There is nothing that David and team haven’t seen over the years – the good, bad, and ugly.”
Vice President, Clinical Operations
WHAT CLIENTS SAY
"Get stuff done when you have to do something no one else has done before."
"They aren’t afraid to tackle difficult scenarios in compressed timelines."
CEO, Medical Device Company
Regulatory-first biostatistics
Support built specifically for FDA-facing programs, from early feasibility through submission and post-market requirements.
Direct communication, faster turn around
Our biostatisticians write the SAP and run the analysis. One person owns both — no separate programmer, no project manager in between.
Versatile Solutions
Engage us for a focused analysis or a full submission, We size the work to the problem.
Proven FDA Experience
Hands-On Experience with FDA Pathways, statistical reviews, and regular interactions, reducing risk and rework.